Linden Matthew Dean, Schneider Mark, Erber Wendy Naomi
Department of Pathology, University of Western Australia, Nedlands, Western Australia, Australia.
J Thromb Thrombolysis. 2004 Jun;17(3):173-6. doi: 10.1023/B:THRO.0000040485.78749.d7.
Acute normovolemic hemodilution (ANH) is used to reduce allogeneic blood transfusion with cardiac surgery. This procedure involves pre-operatively removing and storing a volume of whole blood and replacing the volume with crystalloid. The stored blood is then available for transfusion, if required. Hemodilution associated with ANH may reduce the effectiveness of heparin anticoagulation due to dilution of antithrombin. The aim of this study was to determine if antithrombin concentrations are reduced in patients who undergo one unit of ANH during cardiac surgery.
Patients scheduled for cardiac surgery (n = 71) were grouped according to whether they did or did not undergo ANH pre-operatively. Antithrombin concentrations were measured before and after ANH. This study had 80% power to detect a difference in reduction of antithrombin concentration of 6% between groups following ANH with an alpha error of <0.05. The effect of one unit ANH was expected to cause a difference of 12% or greater.
No significant difference in the concentration of antithrombin between ANH patients and those that did not have ANH, nor was there a difference in the decrease in antithrombin between groups.
The results indicate that one unit of ANH does not significantly reduce the concentration of antithrombin prior to cardiac surgery. Thus patients who undergo one unit of ANH are not at increased risk due to dilution of antithrombin.
急性等容血液稀释(ANH)用于减少心脏手术中的异体输血。该过程包括术前抽取并储存一定量的全血,并用晶体液替代该容量。如果需要,储存的血液可用于输血。与ANH相关的血液稀释可能由于抗凝血酶的稀释而降低肝素抗凝的有效性。本研究的目的是确定在心脏手术期间接受一个单位ANH的患者中抗凝血酶浓度是否降低。
计划进行心脏手术的患者(n = 71)根据术前是否接受ANH进行分组。在ANH前后测量抗凝血酶浓度。本研究有80%的把握度检测ANH后两组之间抗凝血酶浓度降低6%的差异,α错误<0.05。预期一个单位ANH的效果会导致12%或更大的差异。
接受ANH的患者与未接受ANH的患者之间抗凝血酶浓度无显著差异,两组之间抗凝血酶的降低也无差异。
结果表明,一个单位的ANH在心脏手术前不会显著降低抗凝血酶浓度。因此,接受一个单位ANH的患者不会因抗凝血酶稀释而增加风险。